Monogenic control of variations in antipyrine metabolite formation. New polymorphism of hepatic drug oxidation.


To investigate mechanisms that control large variations among normal uninduced subjects in the elimination of the model compound antipyrine (AP) and other drugs, AP was administered to 144 subjects (83 unrelated adults and 61 members of 13 families). Thereafter, at regular intervals for 72 h, the urine of each subject was collected and concentrations of AP… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.